Boston Commerce Ltd

Boston Commerce Limited, formerly known as Boston Bio Systems Limited, announced the appointment of Mrs. Archana Chaitanya Pandya as an Additional Director in the capacity of Whole-Time Director and Chief Financial Officer, effective August 14, 2026, subject to shareholder approval. Mrs. Pandya holds a Bachelor of Commerce degree and is not related to any other directors of the company, and is not debarred from holding the office of Director.

Boston Commerce Limited, formerly known as Boston Bio Systems Limited, will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited.

Boston Commerce Limited, formerly known as Boston Bio Systems Limited, held an Extraordinary General Meeting on August 5, 2026, where shareholders approved the appointment of M/s. S Parth & Company as Co-Statutory Auditors, a scheme for reduction of share capital, borrowing powers under Section 180(1)(c) of the Companies Act, 2013, acquisition of businesses, adoption of a new Memorandum of Association and Articles of Association, and the regularization of the appointments of Ms. Jansi Falgunkumar Patel and Ms. Gunjan Jyotishbhai Leuva as independent directors; the meeting was conducted via video conferencing and remote e-voting was available from August 2, 2026, to August 4, 2026.

Boston Commerce Limited, formerly known as Boston Bio Systems Limited, announced that its Board of Directors approved the shifting of the company's registered office from A.828, Sun West Bank, Ashram Road P.O, Ahmedabad, City Taluka, Gujarat, India, 380009 to OFFICE NO. 11, KRISHNA COMPLEX, Mahatma Gandhi Bridge, Shreyas Colony, Navrangpura, Ahmedabad, T.P. NO.3 FP NO.291, effective August 1, 2026, subject to filings with the Registrar of Companies and other statutory authorities.

Boston Commerce Limited, formerly known as Boston Bio Systems Limited, will hold a board meeting on Saturday, August 1, 2026, to consider and approve the shifting of the company's registered office within the city limits and to transact any other business with the permission of the chair.

Boston Commerce announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 5 August 2026.

Boston Commerce will hold a meeting of the Board of Directors of the Company on 7 July 2026.

Net Loss of Boston Commerce reported to Rs 0.65 crore in the quarter ended March 2026 as against net loss of Rs 0.49 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 0.19 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 0.58 crore in the year ended March 2026 as against net loss of Rs 0.55 crore during the previous year ended March 2025. Sales rose 152.63% to Rs 0.48 crore in the year ended March 2026 as against Rs 0.19 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales00.19 -100 0.480.19 153 OPM %0-257.89 -2.08-289.47 - PBDT-0.68-0.49 -39 -0.58-0.55 -5 PBT-0.68-0.49 -39 -0.58-0.55 -5 NP-0.65-0.49 -33 -0.58-0.55 -5 Powered by Capital Market - Live

Boston Commerce will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Net Loss of Boston Bio Systems reported to Rs 0.01 crore in the quarter ended December 2025 as against net loss of Rs 0.05 crore during the previous quarter ended December 2024. Sales reported to Rs 0.06 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.060 0 OPM %33.330 - PBDT-0.01-0.05 80 PBT-0.01-0.05 80 NP-0.01-0.05 80 Powered by Capital Market - Live